Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts ZNTL Hot Sheet
Join SI Premium – FREE
Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q1 EPS of ($0.67), $0.01 better than the analyst estimate of ($0.68).
For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vail Resorts (MTN) 2200 contracts October 145 puts trade into quarter results
- Prabhudas Lilladher Starts Aditya Birla Sun Life AMC (ABSLAMC:IN) at Buy (1)
- Portland General Electric halts holding company restructuring plan
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
